Aedifica SA

Board/Management Information • Sep 23, 2015

CV - Katrien KESTELOOT

PERSONAL DETAILS

Nationality: Belgian

Full name: KESTELOOT, Katrien Andréa Date and place of birth: Moorslede (Belgium), July 28, 1962 Marital status: married to Dirk Delva, since July 15, 1983 Two children

office: University Hospitals Leuven Finance Director (CFO) Herestraat 49, 3000 Leuven

PROFESSIONAL CAREER

University Hospitals, Leuven (Belgium)

UZ Leuven is the largest university hospital in Belgium (over 1800 beds, annual turnover of 850 million EUR)

Finance Director (CFO) of the University Hospitals Leuven, since May 2002

Responsible for accounting, billing (health insurance & patients), treasury & loan management, planning & budgeting, … (temporary part-time function, since Dec 2014 – cf. infra)

Member of the Management Committee of UPC KU Leuven (academic psychiatric center): since 2006 Member of the Treasury & Investment Committee of KU Leuven (university, hospital and Leuven R&D) Director of Strategy and Financing Systems, University Hospitals Leuven: Feb 1999 – April 2002

Key achievements:

• Developing and operationalizing investment budget cycle
• Developing and implementing annual operational budget cycle linked with the periodical business plans
• Standardization of financial business plan set ups
• Development of long term financial planning tool, to evaluate the financial impact and viability of major construction works
• Developing of & lobbying for improved university hospital funding systems, at the federal and regional government level
• Semi-annual reporting of the financial statements of the hospital, to the different governing bodies (university hospital, university, medical council, works council, …)
• The university hospitals Leuven are in good financial health

Policy Cell, Mrs Maggie De Block, Minister of Public Health & Social Affairs

Minister De Block (Open VLD) is a member of the federal government, established since Oct 2014.

Since Dec. 2014 (part time assignment), expert-adviser for the Minister of Public Health & Social Affairs on hospital financing

(project leader for the reform of the hospital funding system)

Key achievements:

• Development of the Working Plan for the Reform of the Hospital Funding System (Plan was presented to the Commission of Public Health of the Federal Parliament on April 28, 2015)
• Design of the pilot project approach to evaluate reform models

KU Leuven (University of Leuven)

KU Leuven is the oldest (founded in 1425) and largest university in Belgium

Since Oct. 1990: Professor at the Medical School, KU Leuven

(department of public health, Centre for Health Services and Nursing Research) Full professor, since October 2000

Teaching: Financial Management in Health Care, Health Economics, Health financing systems, …. Research areas:

Health technology assessment (mainly cost calculations, economic evaluations) Financing systems in health care (especially hospitals): theoretical and empirical work

Continuing education: regular speaker on health care funding, hospital financing, recent major developments (integrated care, pay for performance, shared savings, accountable care, …) in health care financing

Key achievements:

• Teaching load in several master programs, with good/very good evaluation by students
• Frequent speaker at continuing education programs
• Coordinator of many research projects less intensive since combined with CFO-responsibilities (cf. list of major publications in appendix)

Emmaus (health care institutions)

Emmaus is a non-profit health care holding, consisting of over 20 health care institutions in the province of Antwerp (general and psychiatric hospitals, elderly care institutions, facilities for people with disabilities, child care facilities, …)

Member of the board of directors, since 2006 Member of the (two) hospital boards, since 2006 Member of the financial commission, since 2011 Vice-president of the board, since 2012 Member of the remuneration committee, since 2012 President of the audit committee since 2013 (member since 2006)

Membership of advisory boards

National Hospital Council (NRZV-CNEH): member of the Finance Section (since May 2003) member of several working groups (since May 2003)

Federal Knowledge Centre for Health Care (KCE): member of the Board of Directors, May 2003-Feb 2008; deputy 2009-2014

Multipartite (advisory board on health care): deputy since 2009

RUZB-CHAB (Council of University Hospitals Belgium): member of the Board of Directors, since 2000

Flemish Health Council (Vlaamse Gezondheidsraad), established by the Flemish Government (Jan 1997) chairperson: 1997-200; member 1997-2007

Other (current or former) professional responsibilities

Teaching assignment in several executive educational programs: Vlerick (Leuven-Gent): Management for the Hospital Professional (module hospital financing), since 2005 Tias-Business School (Tilburg University): Executive Master Health Administration (2004-2010)

Faculty Club, VZW1 (business club of the KU Leuven): member of the board of directors, since 2005

Hospital Logistics, NV1(logistic service company, active in health care) member of the board of directors: 2003–June 2010

Unident, NV (dental implant provider) member of the board of directors: 2003–2010 (company taken over by Elysee Dental Europe in 2011)

LSL, NV (laundry services in health care) member of the board of directors, 2003-2007 (company taken over by Malysse NV, co-owner, due to restructuring)

Hospex, NV (real estate company of University Hospitals for non-core infrastructure) member of the board of directors, since 2003

Health Policy (scientific journal): editor-in-chief: 2007-2010; editor: 1999-2007

Johnson & Johnson Fund for Health and Welfare, Koning Boudewijnstichting chairperson of the board: June 2000–February 2008

Flemish Minister of Finance, Budget & Health Policy expert-advisor for health policy: November 1995–July 1999

EDUCATION

June 1985: Master ('licentiaat') in economics, KU Leuven; degree: great distinction

June 1990: Ph.D. in economics, KU Leuven (Essays on Performance Diagnosis and Tacit Cooperation in International Oligopolies) (1988-1989: visiting student at Princeton University, Princeton, NJ, USA)

May 1991: Health Executives Development Program, Cornell University, Ithaca, USA

July 2002: Fellow of the INSEAD Johnson & Johnson European Health Leadership Program

October 2014: Global Health Leadership Forum (GHLF), UC Berkeley & King's Fund, London

¹ VZW = not for profit company

NV = limited liability company

APPENDIX: MOST IMPORTANT PUBLICATIONS

KESTELOOT, K., VAN HERCK, G., 2015, Financieel beleid voor ziekenhuizen, Acco, Leuven/Voorburg – revised edition of Kesteloot & Van Herck (2005) and (2008).

VANDERHEYDEN, S., CASAER, M., KESTELOOT, K., SIMOENS, S., DE RIJDT, T. et al., 2012, Early versus late parenteral nutrition in ICU patients: cost analysis of the EPaNIC trial, Critical Care, 16, 3, R96, http://ccforum.com/content/16/3/R96.

KESTELOOT, K., PEERS, G., DE ROEY, J., CAEYERS, D. VAN RAEMDONCK, D., PIRENNE, J., 2012, Cost of living kidney donation in Belgium, Research report for the Belgian government.

CURRAN, C., KNAPP, M., McDAID, D., TOMASSON, K., ZECHNMEISTER, I., DIERCKX, H., KESTELOOT, K. et al, 2007, Mental health and employment: an overview of patterns and policies across Western Europe, Journal of Mental Health, 16, 2, 195-209.

KESTELOOT, K., 2010, Redesigning Hospital Financing Systems: Insights from Principal-Agent and Contract Theory, Review of Business and Economics, Acco, Leuven, LV, 2, 2010, 190-209.

VAN DEN BERGHE, G., WOUTERS, P., KESTELOOT, K., HILLEMAN, D., 2006, Analysis of healthcare resource utilization with intensive insulin therapy in critically ill patients, Critical Care Medicine, 34, 3, 612-616.

KESTELOOT, K., VAN HERCK, G., 2005, Financiële analyse van ziekenhuizen, Acco, Leuven/Voorburg.

LIEVENS, Y., KESTELOOT, K., VAN DEN BOGAERT, W., 2005, Economic consequence of local control with radiotherapy. Cost analysis of the internal mammary and medial supraclavicular lymph node irradiation in breast cancer, International Journal of Radiation Oncology, Biology, Physics, 63, 4, 1122-1131.

LIEVENS, Y., KESTELOOT, K., VAN DEN BOGAERT, W., 2005, CHART in lung cancer: economic evaluation and incentives for implementation, Radiotherapy and Oncology, 75, 2, 171-178.

CLEEMPUT, I., KIND, P., KESTELOOT, K., 2004, Re-scaling social preference data : implications for modelling, European Journal of Health Economics, 5, 4, 290-298.

CLEEMPUT, I., KESTELOOT, K., VANRENTERGHEM, Y., DE GEEST, S., 2004, The economic implications of nonadherence after renal transplantation, Pharmaeconomics, 22, 18, 1217-1234.

CLEEMPUT, I., KESTELOOT, K., MOONS, P., VANRENTERGHEM, Y., SQUIFFLET, J.-P., VAN HOOFF, J., DE GEEST, S., 2004, The construct and concurrent validity of the EQ-5D in a renal transplant population, Value in Health, 7, 4, 499-509.

LIEVENS, Y., VAN DEN BOGAERT, W., KESTELOOT, K., 2003, Activity-Based Costing : A Practical Model for Cost Calculation in Radiotherapy, International Journal of Radiation Oncology, Biology, Physics, 57, 2, 522-535.

CLEEMPUT, I., KESTELOOT, K., DE GEEST, S., DOBBELS; F., VANRENTERGHEM, Y., 2003, Health Professionals Perception on Health Status after Renal Transplantation : a Comparison with Transplantation Candidates' Expectations, Transplantation, 15, 76 (1), 176-182.

CLEEMPUT, I., KESTELOOT, K., S. DE GEEST, 2002, A review of the literature on the economics of noncompliance. Room for methodological improvement, Health Policy, 59, 1, 65-94.

CLEEMPUT, I., KESTELOOT, K, 2002, Economic implications on non-compliance in health care, The Lancet, 359, 9324, 2129-2130.

JEGERS, M., KESTELOOT, K., DE GRAEVE, D., GILLES, W., 2002, A typology for provider payment systems in health care, Health Policy, 60, 3, 255-273.

KESTELOOT, K., Y. LIEVENS & E. VAN DER SCHUEREN, 2000, Improved management of radiotherapy departments through accurate cost data, Radiotherapy & Oncology, 55, 251-262.

CLEEMPUT I. & K. KESTELOOT, 2000, Health Technology Assessment in Belgium - country report, in BANTA, H.D. & W.J. OORTWIJN (Eds), International Journal of Technology Assessment in Health Care, 16, 2, 325-346.

COUCKE, K. & K. KESTELOOT, 2000, A comparison of health care financing policies for incontinence products in European countries, European Urology, 37, 36-42..

LIEVENS, Y., K. KESTELOOT, A. RIJNDERS, G. KUTCHER, W. VAN DEN BOGAERT, 2000, Differences in palliative radiotherapy for bone metastases within Western European countries, Radiotherapy and Oncology, 56, 297-303.

LIEVENS, Y., W. VAN DEN BOGAERT, A. RIJNDERS, G. KUTCHER, K. KESTELOOT, 2000, Palliative radiotherapy practice within Western European countries : impact of the radiotherapy financing system ?, Radiotherapy and Oncology, 56, 289-295.

KESTELOOT, K., 1999, Public financing systems for radiology - Experience in 12 European countries, European Radiology, 9, 166-73.

KESTELOOT, K., 1999, Disease management: a new technology in need of critical assessment, International Journal of Technology Assessment in Health Care, 15, 3, 506-519.

KESTELOOT, K. & N. VOET, 1998, Incentives for co-operation in quality improvement among hospitals: impact of the reimbursement system, Journal of Health Economics,1998, 17, 6, 701-28.

KESTELOOT, K. & A. BAERT, 1997, Health care policy towards medical imaging - Experience in some European countries, Academic Radiology, 5 (suppl. 2) S377-83.

KESTELOOT, K. & R. VEUGELERS, 1995, Stable R&D cooperation with spillovers, Journal of Economics and Management Strategy, 4, 4, 651-72.

KESTELOOT, K., S. POCCESCHI & E. VAN DER SCHUEREN, 1995, The reimbursement of the expenses for medical treatment received by 'transnational' patients in EC-countries, Health Policy, 33, 1, 43-57.

KESTELOOT, K., 1995, The economics of reimbursement and technological change in cancer care, European Journal of Cancer, 31A, 9, 1406-9.

VEEREMAN-WAUTERS, G., K. KESTELOOT & E. EGGERMONT, 1994, Pediatric endoscopy: the difference between two continents, Acta Endoscopica, 24, 2, 103-7.

VEUGELERS, R. & K. KESTELOOT, 1994, On the design of stable joint ventures, European Economic Review, 38,1799-1815.

KESTELOOT, K. & F. PENNINCKX, 1993, The costs and effects of laparoscopic versus surgical cholecystectomies, Health Economics, 2, 4, 303-12.

KESTELOOT, K., A. DUTREIX & E. VAN DER SCHUEREN, 1993, Quality Assurance in Radiotherapy - Economic Criteria to support decision making, International Journal of Technology Assessment in Health Care, 9, 2, 274-85.